Comparison of the [13C]Glucose Breath Test to the Hyperinsulinemic-Euglycemic Clamp When Determining Insulin Resistance

Diabetes Care

Volumn 27, Issue 2, 2004, Pages 441-447

  Lewanczuk, Richard Z ^a   Paty, Breay W ^a   Toth, Ellen L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; CARBON DIOXIDE; GLUCOSE; INSULIN; CARBON;

ADULT; ARTICLE; BREATH ANALYSIS; CARBON 13 GLUCOSE BREATH TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SENSITIVITY INDEX; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; OBESITY; QUICKI INDEX; SCORING SYSTEM; STATISTICAL MODEL; ANALYSIS OF VARIANCE; BLOOD; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; METABOLISM; METHODOLOGY; PHYSIOLOGY; REFERENCE VALUE; REGRESSION ANALYSIS; REPRODUCIBILITY;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BREATH TESTS; CARBON ISOTOPES; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 0842311556     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.2.441     Document Type: Article

References (26)

1. King H, Aubert RE, Herman WH: Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998
2. Boyle JP, Honeyenu AA, Narayan KM, Hoerger TJ, Geiss IS, Chen H, Thompson TJ: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 24:1936-1940, 2001
3. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeidner JS, Kahn CR: Role of glucose and insulin resistance in development of type II diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
4. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
5. Beck Nielsen H, Groop LC: Metabolic and genetic characterization of prediabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714-1721, 1994
6. Matthaei S, Stumvoll M, Kellerer M, Häring HU: Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21:585-618, 2000
7. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16: 642-652, 1993
8. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 14:539-553, 1998
9. Pyorla K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-141, 1979
10. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
11. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
12. Facchini FS, Hua N, Abbasi F, Reaven GM: Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86:3574-3578, 2001
13. Hanley AJG, Williams K, Stern MP, Haffner SM: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25:1177-1184, 2002
14. Tuomilehto J, Lindsrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M, for the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
15. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
16. Diabetes Prevention Program Research Group: Reduction in the incidence of type diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
17. Chiasson J, Josse RC, Bomis R, Hanefeld M, Darasik A, Laakso M, for the STOP-NIDDM Trial Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2071-2077, 2002
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turer RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
19. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quan MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410, 2000
20. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiai F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23:57-63, 2000
21. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y: QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 87:2906-2908, 2002
22. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L: Incorporation of the fasting plasma FFA concentration into QUIKI improes its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 86:4776-4781, 2001
23. 13C nuclear magnetic resonance spectroscopy. New Engl J Med 322: 223-228, 1990
24. 2 in high-glucose medium. Diabetes 44:520-526, 1995
25. Radziuk J: Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85:4426-4433, 2000
26. Duncan GE, Hutson AD, Stacpoole PW: QUICKI does not accurately reflect changes in insulin sensitivity with exercise training. J Clin Endocrinol Metab 86: 4115-4119, 2001